{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:40Z","timestamp":1787024560267,"version":"build-2736575974"},"reference-count":18,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s486272","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:25:11Z","timestamp":1732062311000},"page":"1089-1094","source":"Crossref","is-referenced-by-count":2,"title":["Concentrations of Irinotecan and SN-38 in the Ascites and the Fluid Product of Cell-Free and Concentrated Ascites Reinfusion Therapy 9 Days After Administration of Irinotecan in a Patient with Gastric Cancer: A Case Report"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Keisuke","family":"Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Tanie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Ikematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyo","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narikazu","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00228-010-0885-3","volume":"66","author":"Ahn","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/0929867033368600","volume":"10","author":"Hulme","year":"2003","journal-title":"Curr Med Chem"},{"key":"ref3","first-page":"2188","volume":"29","author":"Natsui","year":"2002","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref4","first-page":"1505","volume":"28","author":"Maruyama","year":"2001","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref5","first-page":"1858","volume":"27","author":"Maruyama","year":"2000","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00002480-197700230-00189","volume":"23","author":"Inoue","year":"1977","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/1744-9987.12469","volume":"20","author":"Kozaki","year":"2016","journal-title":"Ther Apher Dial"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.transci.2017.08.018","volume":"56","author":"Ito","year":"2017","journal-title":"Transfus Apher Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1111\/jgh.15620","volume":"36","author":"Ito","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ejso.2015.04.013","volume":"41","author":"Yamaguchi","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00520-017-3980-5","volume":"26","author":"Hanada","year":"2018","journal-title":"Support Care Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1007\/s00520-020-05401-4","volume":"28","author":"Nagata","year":"2020","journal-title":"Sup Care Can"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1349-7006.1995.tb02995.x","volume":"86","author":"Sasaki","year":"1995","journal-title":"Jpn J Cancer Res"},{"key":"ref14","unstructured":"Bioanalytical Method Validation Guidance for Industry [Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-199733040-00001","volume":"33","author":"Chabot","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"ref16","first-page":"6921","volume":"60","author":"Ando","year":"2000","journal-title":"Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/FPC.0b013e328014341f","volume":"17","author":"Minami","year":"2007","journal-title":"Pharm Genomics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006379730137","volume":"18","author":"Combes","year":"2000","journal-title":"Invest New Drugs"}],"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/97468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/97468","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:25:19Z","timestamp":1732062319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/concentrations-of-irinotecan-and-sn-38-in-the-ascites-and-the-fluid-pr-peer-reviewed-fulltext-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":18,"URL":"https:\/\/doi.org\/10.2147\/ott.s486272","relation":{},"ISSN":["1178-6930"],"issn-type":[{"value":"1178-6930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}